Surging Cancer Occurrence Is Set To Drive Digital Mammography Equipment Demand

The global digital mammography equipment market is anticipated to experience a booming growth over the projected timeframe. The market traction can be ascribed to the increasing cancer cases all over the world. The radiologic signs of breast cancer consist of mass lesions, asymmetrical images of both breasts, architectural distortion, and microcalcifications. To facilitate timely and accurate cancer detection, factors such as data acquisition and display & interpretation of the mammogram results should be optimized, and a procedure standardization should be maintained.  

Quality assurance plays a vital role in test result optimization and also includes corporative efforts of radiologists, technologist (radiographer), medical physicist, and equipment manufacturer. The market has the potential to improve the efficiency in image processing, archiving, and retrieval with an added benefit of decreased costs, operational complexity, and waste disposal challenges associated with chemical processing of the film. Digital mammography has enhanced the ability to perform computerized diagnosis using 3D tomosynthesis and contrast subtraction studies. All the aforementioned factors have resulted in a steady replacement of traditional mammography techniques and shift towards digital systems.

Access "117" page research report with TOC on "Digital Mammography Equipment Market" available with Radiant Insights, Inc.@ https://www.radiantinsights.com/research/2013-2028-report-on-global-digital-mammography-equipment-market

The market has been broadly segmented into product type, application, sales channel, and key regions. Geographically, the market has been segmented into North America, Europe, Asia Pacific, South America, and the Middle East & Africa. Asia Pacific is likely to emerge as a dominant region during the forecast timeframe and it can be primarily attributed to the expanding nature of the medical R&D, coupled with the increasing number of foreign players starting to invest in the developing countries like China and India. Furthermore, Europe also pays a key role in the global revenue generation as the regional players have largely invested in the development of advanced technologies and are focusing on expanding their reach over foreign countries. 

Some of the key players operating in the market are Hologic, GE Healthcare, Carestream Health, Philips Healthcare, Siemens Healthcare, Fujifilm, Planmed, Metaltronica, IMS, General Medical Merate, Anke High-Tech, ITALRAY, AMICO JSC, ADANI, Angell Technology, and BMI Biomedical International. Industry players are conducting ground-breaking research and technological advancements to change the face of early diagnosis and treatment. Market products like Seno Iris GE Mammography Solution developed by GE Healthcare and Digital X-ray devices by Philips Healthcare have been created with superior diagnostic clarity and concise results. Developing countries like India are extensively supporting collaborations and partnerships with fellow contenders. For instance, in March 2020, Fujifilm India Pvt Ltd and Vijaya Diagnostic Centre collaborated to create awareness programs about the early detection of breast cancer and the available therapeutic options. Several seminars and awareness programs have emphasized on the clinical relevance of the available technology like digital mammography.